Overview

Evaluation of the Effects of Treatment of Psycho-stimulant and Cannabis-dependent Users in Israel

Status:
Unknown status
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This study evaluates the effects of psychological and pharmacological treatment of regular users of cannabis and psychostimulants in a treatment center (Kfar Izun) in Israel. The participants will undergo psychological evaluation before and during treatment and follow up at 4 months. Ten participants will undergo brain imaging of the dopamine receptor D2 in order to evaluate the effects of treatment on dopamine turnover in the brain. A control group of psychiatric in-patients undergoing treatment for psychiatric illness with be recruited from Geha Hospital in Israel. It is predicted that successful treatment of regular users of cannabis will be resulted in improvement in anxiety, depression and psychotic symptoms as well as in upregulation of dopamine turnover in participants that will undergo brain imaging.
Phase:
N/A
Details
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Treatments:
Central Nervous System Stimulants
Risperidone